Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis FactorsMichele Del Vecchio, Andrea Anichini, Stefania Canova et al.|Clinical Cancer Research|2010Cited by 59